% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • biotechpicklist biotechpicklist Mar 6, 2014 8:17 PM Flag

    While it is nice to pump all RNAi companies people are forgetting something about RXII

    ARWR and TKMR keep reaching new highs and it seems they have good delivery vehicles, but RXII still trades at such a low market valuation. I guess its good for those who are continuing to load up on RXII shares.

    But investors seem to be forgetting something about RXI-109 and that is it is being sold right now in Europe to patients as a "Specials" designation under EMA law. The specials designation allows pharmaceutical companies to sell their drug to doctors provided that proper efficacy and safety is established.

    With this in mind we can conclude that RXI-109 is proven to reduce scars in humans greater than placebo drugs which honestly do nothing, and that it is a very safe injection drug. What other RNAi company can claim it is being sold right now to doctors in Europe? We have something golden here with RXII and patience will win again IMO

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.410.00(-0.24%)Jul 31 4:00 PMEDT